drugset / Trial / NCT06608030

Effect of Esketamine on Perioperative Negative Mood in Patients Undergoing Cardiac Valve Surgery

NCT06608030 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

A multicenter, randomized controlled, blinded prospective study to investigate the effects of esketamine on perioperative anxiety and depression in patients undergoing cardiac valve surgery.

Timeline

Start
2024-09-23
Primary completion
2025-04-07
Completion
2025-04-30

Outcome

Met primary endpoint

paper the esketamine group had significantly lower rates of depression (7.0 % vs. 31.0 %; P < 0.001) and anxiety (11.3 % vs. 35.2 %; P < 0.001) PMID 41285329 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.3 mg/kg Intravenous